anti-Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 9 (SLC2A9) Anticorps

SLC2A9 encodes a member of the SLC2A facilitative glucose transporter family. De plus, nous expédions et et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
SLC2A9 56606 Q9NRM0
SLC2A9 501925  
SLC2A9 117591  
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-SLC2A9 Anticorps sur anticorps-enligne.fr

Showing 10 out of 59 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Livraison Prix Détails
Boeuf (Vache) Lapin Inconjugué WB WB Suggested Anti-SLC2A9 Antibody Titration:  0.2-1 ug/ml  ELISA Titer:  1:1562500  Positive Control:  HepG2 cell lysate SLC2A9 is supported by BioGPS gene expression data to be expressed in HepG2 Host:  Rabbit  Target Name:  SLC2A9  Sample Type:  Human Fetal Lung  Antibody Dilution:  1.0ug/ml 100 μL 2 to 3 Days
$319.00
Détails
Humain Lapin Inconjugué IHC (p), WB Western blot analysis of GLUT9 expression in HepG2 whole cell lysates (lane 1) and A549 whole cell lysates (lane 2). GLUT9 at 55KD was detected using rabbit anti- GLUT9 Antigen Affinity purified polyclonal antibody at0.5 μg/mL. The blot was developed using chemiluminescence (ECL) method 100 μg 4 to 6 Days
$280.00
Détails
Boeuf (Vache) Lapin Inconjugué WB 100 μL 11 to 14 Days
$581.17
Détails
Humain Lapin Inconjugué WB Anti- GLUT9 antibody, Western blotting All lanes: Anti GLUT9  at 0.5ug/ml Lane 1: Rat Liver Tissue Lysate at 50ug Lane 2: A549 Whole Cell Lysate at 40ug Lane 3: HELA Whole Cell Lysate at 40ug Predicted bind size: 59KD Observed bind size: 59KD 100 μg 4 to 6 Days
$240.00
Détails
Humain Lapin Inconjugué WB Western blot analysis in HepG2 cell line lysates (35ug/lane). 400 μL 2 to 3 Days
$515.63
Détails
Humain Lapin Inconjugué ELISA, WB 100 μL 2 to 3 Days
$446.88
Détails
Humain Lapin Inconjugué WB   100 μg 11 to 14 Days
$463.83
Détails
Humain Lapin Inconjugué ELISA, WB   100 μL 11 to 14 Days
$1,079.83
Détails
Souris Lapin Inconjugué WB 100 μL 6 to 7 Days
$545.42
Détails
Humain Lapin Inconjugué WB The SLC2A9 polyclonal antibody  is used in Western blot to detect SLC2A9 in human kidney membrane prep. 100 μL 11 to 12 Days
$356.00
Détails

anti-SLC2A9 Anticorps mieux référencés

  1. Human Polyclonal SLC2A9 Primary Antibody pour ICC, IF - ABIN316364 : Tomioka, Tamura, Takada, Shibata, Suzuki, Uchida, Hosoyamada: Immunohistochemical and in situ hybridization study of urate transporters GLUT9/URATv1, ABCG2, and URAT1 in the murine brain. dans Fluids and barriers of the CNS 2016 (PubMed)
    Show all 4 Pubmed References

  2. Human Polyclonal SLC2A9 Primary Antibody pour WB - ABIN540295 : Le, Shafiu, Mu, Johnson: SLC2A9--a fructose transporter identified as a novel uric acid transporter. dans Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008 (PubMed)
    Show all 3 Pubmed References

  3. Mouse (Murine) Polyclonal SLC2A9 Primary Antibody pour WB - ABIN540293 : Anzai, Ichida, Jutabha, Kimura, Babu, Jin, Srivastava, Kitamura, Hisatome, Endou, Sakurai: Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. dans The Journal of biological chemistry 2008 (PubMed)
    Show all 3 Pubmed References

  4. Cow (Bovine) Polyclonal SLC2A9 Primary Antibody pour WB - ABIN2781547 : Gaccioli, White, Capobianco, Powell, Jawerbaum, Jansson: Maternal overweight induced by a diet with high content of saturated fat activates placental mTOR and eIF2alpha signaling and increases fetal growth in rats. dans Biology of reproduction 2013 (PubMed)
    Show all 2 Pubmed References

  5. Human Polyclonal SLC2A9 Primary Antibody pour IHC (p), WB - ABIN438433 : Roma, Ovadje, Steckle, Nicoletti, Saleem, Pandey: Selective Induction of Apoptosis by Azadarichta indica Leaf Extract by Targeting Oxidative Vulnerabilities in Human Cancer Cells. dans Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2015 (PubMed)

Plus d’anticorps contre SLC2A9 partenaires d’interaction

Human Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 9 (SLC2A9) interaction partners

  1. association of genetic variant rs3733591 with gout in Malaysia

  2. No significant associations between the SNPs in SLC2A9 and Parkinson risk among men or women.

  3. the present study demonstrates that SLC2A9 may be a novel tumor suppressor gene and a potential therapeutic target in hepatocellular carcinoma

  4. Some of these single nucleotide polymorphisms in SLC2A9 may increase the risk of hyperuricemia.

  5. Placental expression of at least three GLUT isoforms, i.e. GLUT-1, GLUT-4, and GLUT-9, may be involved in the intensification of intrauterine fetal growth in pregnancies complicated by gestational diabetes mellitus and pregnancy complicated by diabetes mellitus, type 1.

  6. Findings provide new insights into the genetic architecture of serum urate, and highlight molecular targets in SLC22A12 and SLC2A9 for lowering serum urate and preventing gout.

  7. Interaction analysis demonstrated that the following genotypes: MS4A14 DI+II, SLC2A DI+II and ABCB 5 CG+GG, were associated with a prothrombin time >/=12 sec and with Recurrent pregnancy loss (RPL) risk

  8. The study identifies the key residues for urate specific transport in human glucose transporter 9. The data data indicate that urate transport in human glucose transporter 9 involves several structural elements rather than just a unique substrate binding pocket.

  9. GLUT9 SNPs influence the renal handling of uric acid and modulate serum urate levels and the response to treatment in patients with uric acid overproduction due to Lesch-Nyhan disease.

  10. SLC2A9 non-synonymous variants rs2280205 and rs2276961 are not associated with gout in Cameroonians

  11. URAT1 and GLUT9 mutations in Spanish patients with renal hypouricemia

  12. SLC2A9/GLUT9 rs1172228 CC genotype in gout had significant associations with higher levels of serum uric acid, renal calculi and a positive family history of gout.

  13. Combined exposure to the four high-risk genotypes of ALPK1 and the uric-acid-related loci of ABCG2, SLC2A9, and SLC22A12 was associated with an increased gout risk and a high PPV for gout.

  14. This study demonstrated that reduced glucose transporter-1 in brain derived circulating endothelial cells in mild Alzheimer's disease patients.

  15. Immunoreactivity of GLUT9 was observed on the apical side of the cytoplasm of epithelial cells in the choroid plexus and in the cilia of ependymal cells of the human brain.

  16. genetic association studies in population in China: Data suggest that SNPs in SLC2A9 (rs11722228, rs3775948) and ABCG2 (rs2231142) are associated with diabetic kidney disease in subjects with type 2 diabetes in the population studied. (SLC2A9 = solute carrier family 2 member 9; ABCG2 = ATP binding cassette subfamily G member 2)

  17. This meta-analysis shows that the rs12510549, rs16890979, and rs1014290 polymorphisms of SLC2A9 protect against the development of gout in Caucasians and/or Asians.

  18. The results of the study confirmed the presence of GLUT-1, GLUT-4 and GLUT-9 proteins in the trophoblast from both, uncomplicated and diabetic pregnancies. In addition, insulin therapy may increase placental expression of GLUT-4 and GLUT-9, and partially GLUT-1, in women with pregestational and gestational diabetes mellitus.

  19. Meta-analysis. This study demonstrated that the genetic susceptibility for gout is associated with the SLC2A9 gene polymorphisms. Four of them except for the rs3733591 are protective SNPs in Caucasians, and rs16890979 and rs1014290 are protective SNPs in both Caucasians and Asians, while rs3733591 may be susceptibility SNP in Asians.

  20. Each A-allele of the SLC2A9 rs7442295 was associated with 9% higher plasma urate and hazard ratios of 1.07 (1.01-1.14) for cancer incidence and 1.07 (1.02-1.13) for all-cause mortality.

Mouse (Murine) Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 9 (SLC2A9) interaction partners

  1. SLC2A9 regulates urate reabsorption in the mouse kidney.

  2. Its anti-hyperuricemic mechanisms may be ascribed to its inhibition of XOD and its up-regulation of organic anion transporter 1 (OAT1) and down-regulation of glucose transporter 9 (GLUT9).

  3. intestinal uric acid transporter SLC2A9 has a role in early-onset metabolic syndrome in a mouse model

  4. Studies confirm the expression of GLUT9a and GLUT9b in murine and human beta-cells.

  5. blocking GLUT9 expression during preimplantation development had no effect on glucose transport or apoptosis but transfer of these embryos resulted in increased pregnancy loss, suggesting that GLUT9 is critical for early preimplantation development.

  6. mGLUT9 protein expression was significantly increased in the kidney and liver from streptozotocin-induced diabetic mice compared with nondiabetic animals

  7. Glucose uptake via GLUT9a and GLUT9b likely affects normal spermatogenesis, steroidogenesis, and sperm function in the mouse.

  8. Characterize in more detail the transport properties of mouse GLUT9 and provide evidence that it functions as a urate uniporter.

  9. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy.

SLC2A9 profil antigène

Profil protéine

This gene encodes a member of the SLC2A facilitative glucose transporter family. Members of this family play a significant role in maintaining glucose homeostasis. The encoded protein may play a role in the development and survival of chondrocytes in cartilage matrices. Two transcript variants encoding distinct isoforms have been identified for this gene.

Gene names and symbols associated with SLC2A9

  • solute carrier family 2 member 9 (SLC2A9) anticorps
  • solute carrier family 2 (facilitated glucose transporter), member 9 S homeolog (slc2a9.S) anticorps
  • solute carrier family 2 member 9 (Slc2a9) anticorps
  • solute carrier family 2 (facilitated glucose transporter), member 9 L homeolog (slc2a9.L) anticorps
  • solute carrier family 2 (facilitated glucose transporter), member 9 (SLC2A9) anticorps
  • solute carrier family 2 (facilitated glucose transporter), member 9 (Slc2a9) anticorps
  • DKFZp469N0218 anticorps
  • Glut9 anticorps
  • glutx anticorps
  • MGC80340 anticorps
  • SLC2A9 anticorps
  • SLC2a9A anticorps
  • SLC2A9B anticorps
  • uaqtl2 anticorps
  • URATv1 anticorps

Protein level used designations for SLC2A9

GLUT-9 , glucose transporter type 9 , human glucose transporter-like protein-9 , solute carrier family 2, facilitated glucose transporter member 9 , urate voltage-driven efflux transporter 1 , solute carrier family 2 (facilitated glucose transporter), member 9 , solute carrier family 2, member 9 protein , Solute carrier family 2, facilitated glucose transporter member 9 , facilitated glucose transporter, type 9 , solute carrier family 2, member 9

GENE ID SPECIES
56606 Homo sapiens
422843 Gallus gallus
432243 Xenopus laevis
465225 Pan troglodytes
479093 Canis lupus familiaris
501925 Rattus norvegicus
100158398 Xenopus laevis
100172526 Pongo abelii
117591 Mus musculus
100728307 Cavia porcellus
Fournisseurs de qualité sélectionnés pour anti-SLC2A9 (SLC2A9) Anticorps
Avez-vous cherché autre chose?